The purpose of this study is to assess the efficacy of Aprepitant + standard antiemetic regimen in reducing postoperative nausea and vomiting after laparoscopic gastric sleeve versus placebo + standard antiemetic regimen
After being informed about the study, all patients who provide written informed consent and meet the eligibility requirements will be randomized in a triple-blind manner (participant, evaluator, and investigator) in a 1:1 ratio to Aprepitant (80 or 125 mg) + standard antiemetic regimen (once two hours before surgery) or placebo + standard antiemetic regimen(once two hours before surgery). The standard antiemetic regimen will be Ondansetron 8 mg + Metoclopramide 10 mg + Dexamethasone 8 mg
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
400
80 or 125 mg tablet + standard antiemetic regimen, once two hours before surgery
Placebo + standard antiemetic regimen, once two hours before surgery
Hospital General Tlahuac
Mexico City, Mexico
Patient's postoperative nausea and vomiting evaluation at 0 hrs (Rhodes index)
Change of postoperative nausea and vomiting after laparoscopic gastric sleeve using Rhodes scale
Time frame: 0 postoperative hours
Patient's postoperative nausea and vomiting evaluation at 6 hrs (Rhodes index)
Change of postoperative nausea and vomiting after laparoscopic gastric sleeve using Rhoades scale
Time frame: 6 postoperative hours
Patient's postoperative nausea and vomiting evaluation at 12 hrs (Rhodes index)
Change of postoperative nausea and vomiting after laparoscopic gastric sleeve using Rhoades scale
Time frame: 12 postoperative hours
Patient's postoperative nausea and vomiting evaluation at 24 hrs (Rhodes index)
Change of postoperative nausea and vomiting after laparoscopic gastric sleeve using Rhoades scale
Time frame: 24 postoperative hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.